Outpatient therapeutic ERCP: a series of 262 consecutive cases,☆☆,

https://doi.org/10.1016/S0016-5107(96)70097-4Get rights and content

Abstract

Background: Because of possible complications, it has been common practice to admit most if not all patients undergoing therapeutic ERCP. Therefore, little descriptive data exist on the safety of outpatient therapeutic ERCP.

Methods: We assessed 262 consecutive ERCPs in 209 patients undergoing outpatient therapeutic ERCP over a 5-year period, with particular attention to the development of complications. All outpatient endoscopic sphincterotomies and stent placements performed over a 5-year period were prospectively entered into an ongoing data base that was used for the analysis. In addition, hospital and office records for all patients were retrospectively reviewed, including a 30 to 45 day follow-up in a private office setting.

Results: Suspected or documented choledocholithiasis was the most common indication for ERCP and was present in 132 (50%), followed by malignant obstruction in 77 (29%), type I sphincter of Oddi dysfunction (on the basis of symptoms, liver test abnormalities, and bile duct dilatation) in 36 (14%), chronic pancreatitis in 10 (3.8%), HIV cholangiopathy in 4 (1.5%), and other conditions in 3 (1.1%). Overall, 181 patients (69%) underwent a sphincterotomy. The 30-day post-ERCP complication rate was 5.7% (95% CI: 3.2% to 9.3%), occurring in 15 of 262 cases. Complications necessitating hospitalization developed in 9 of the 262 ERCPs for a rate of 3.4% (95% CI: 1.6% to 6.4%). The mean duration of hospital stay among patients admitted for a complication was 2.7 ± 1.8 days (range, 1 to 7 days). All patients were discharged without permanent sequelae. No 30-day procedure-related fatalities were reported.

Conclusion: In this selected series of 262 consecutive cases, endoscopic sphincterotomy and stent placement were safely performed in an ambulatory setting. Prior to recommending a generalized change in existing practice, however, this finding requires validation with larger series of cases, including the performance of other outpatient therapeutic ERCP techniques. (Gastrointest Endosc 1996;44:443-9.)

Section snippets

Patient selection

Over a 5-year period, 1291 ERCPs were completed by a single endoscopist at the Montreal General Hospital. Of these, 590 (46%) were performed on an outpatient basis. Patients who had ERCP performed on an outpatient basis were those who fulfilled the following criteria: any nonadmitted patient exhibiting an American Society of Anaesthesiologists (ASA) score less than or equal to 3,21 without coagulopathy or active cholangitis, and who lived within 30 minutes of the Montreal General Hospital or

Study population

Overall, 262 consecutive outpatient ERCPs were performed in 209 patients. The study population (Table 1) included 77 (37%) men and 132 (63%) women. The mean age was 51.9 ± 31.3 years (range, 16 to 98). Sixty-five (31%) patients resided within the immediate city limits, 85 (41%) lived within 30 minutes of the Montreal General Hospital, with the remaining 59 (28%) residing at further distances from the Montreal General Hospital. At the time of ERCP, 72 (34%) patients were receiving no

DISCUSSION

Therapeutic ERCP procedures are among the most effective of currently available techniques for the management of pancreaticobiliary disorders. They are also among the most complex and hazardous that endoscopists perform today, yet are quite safe when carried out by an experienced endoscopist.25 Nonetheless, significant complications do occasionally develop, even in experienced hands. Large prospective and retrospective series have defined the incidence of complications arising from ERCP. These

References (57)

  • BF Hannigan et al.

    Hyperamylasemia after ERCP with ionic and non-ionic contrast media

    Gastrointest Endosc

    (1985)
  • SM Muhldorfer et al.

    Complications of therapeutic gastrointestinal endoscopy

    Endoscopy

    (1992)
  • B Neuhaus et al.

    Complications of endoscopic sphincterotomy and their treatment

    Endoscopy

    (1981)
  • PB Cotton et al.

    Computer analysis of a decade of ERCP

    Gut

    (1981)
  • J Escourrou et al.

    Early and late complications after endoscopic sphincterotomy for biliary lithiasis with and without the gallbladder in situ

    Gut

    (1984)
  • IC. Roberts-Thomason

    Endoscopic sphincterotomy of the papilla of Vater: an analysis of 300 cases

    Aust NZ J Med

    (1984)
  • M Freeman et al.

    Hemmorhage from endoscopic sphincterotomy (ES): a prospective, multicenter, 30-day study

    Gastrointest Endosc

    (1994)
  • M Freeman et al.

    Pancreatitis from endoscopic sphincterotomy (ES): a prospective, multicenter, 30-day study

    Gastrointest Endosc

    (1994)
  • S Loperfido et al.

    Major complications from diagnostic and therapeutic ERCP: a prospective multicenter study

    Gastroenterology

    (1995)
  • KI. Shults

    The experience of use of endoscopic papillotomy

    Klin Med (Mosk)

    (1987)
  • J Boender et al.

    Endoscopic papillotomy for common bile duct stones: factors influencing the complication rate

    Endoscopy

    (1994)
  • N Landoni et al.

    Endoscopic sphincterotomy. Its complications and their follow-up

    Acta Gastroenterol Latinoam

    (1992)
  • T Leese et al.

    Successes, failures, early complications and their management following endoscopic sphincterotomy: results in 394 consecutive patients from a single centre

    Br J Surg

    (1985)
  • D Vaira et al.

    Endoscopic sphincterotomy in 1000 consecutive patients

    Lancet

    (1989)
  • MH. Urban

    Endoscopic retrograde cholangiopancreatography. A diagnostic outpatient procedure

    AORN J

    (1989)
  • JH Siegel

    Endoscopic papillotomy in the treatment of biliary tract disease—258 procedures and results

    Dig Dis Sci

    (1981)
  • RB Passi et al.

    Endoscopic papillotomy

    Surgery

    (1981)
  • WD Owen et al.

    ASA physical status classification: a study of consistency of ratings

    Anesthesiology

    (1978)
  • Cited by (40)

    • Development and Validation of a Prediction Model for Admission After Endoscopic Retrograde Cholangiopancreatography

      2015, Clinical Gastroenterology and Hepatology
      Citation Excerpt :

      The majority of post-ERCP complications (>70%) can be identified within the first 6 hours after procedure.9 As reflected in these data, our practice has been to observe almost all of our patients for several hours after their procedure, with selective testing of serum amylase/lipase in the PACU for those at risk for PEP.5–7,10,18,19 However, these data were generated in an era of moderate sedation, where patients would receive high doses of opiates for sedation that could have masked the symptoms of post-ERCP complication.

    • ERCP as an outpatient treatment: a review

      2008, Gastrointestinal Endoscopy
      Citation Excerpt :

      For example, there may be a difference in the risk for post-ERCP complications between pancreatic-stent placement and biliary-stent placement or between a pancreatic and a biliary sphincterotomy. Unfortunately, most reviewed studies did not distinguish between these treatments.5,10-12,15 In addition, patients who were undergoing a high-risk ERCP procedure (ie, pancreatic therapy), associated with SOD or with concurrent comorbidity were already scheduled for 24-hour postprocedural observation in some studies.5,11-13,15

    • Complications after ERCP in patients with primary sclerosing cholangitis

      2008, Gastrointestinal Endoscopy
      Citation Excerpt :

      The study protocol was reviewed and approved by the University of Washington Institutional Review Board. Sample size was calculated by estimating a complication rate of 18% and 6% for PSC and non-PSC indications, respectively, on the basis of available literature.3,4,16,19-26 Assuming an α error of 5%, a sample size of 68 in each group was estimated to result in a 70% power to detect differences.

    View all citing articles on Scopus

    From the Montreal General Hospital, Montreal, Quebec, Canada.

    ☆☆

    Reprint requests: Alan N. Barkun, MD, Gastroenterology, Room D7.148, The Montreal General Hospital, 1650 Cedar Ave., Montreal, Quebec, CANADA, H3G 1A4.

    37/1/72877

    View full text